International Journal of Tuberculosis and Lung Disease

Papers
(The H4-Index of International Journal of Tuberculosis and Lung Disease is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The impact of COVID-19 on TB: a review of the data149
Post-tuberculosis lung health: perspectives from the First International Symposium94
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-1969
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease59
The Global Asthma Report 202243
Impact of COVID-19 on TB diagnosis in Northeastern Brazil39
COVID-19 and tuberculosis—threats and opportunities39
New diseases and old threats: lessons from tuberculosis for the COVID-19 response38
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria33
Impact of COVID-19 on tuberculosis control in China32
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China30
Mask wearing to complement social distancing and save lives during COVID-1929
Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review28
Tobacco control in China and the road to Healthy China 203027
A partially randomised trial of pretomanid, moxifloxacin and pyrazinamide for pulmonary TB26
Tuberculosis contact investigation and short-course preventive therapy among young children in Africa24
The COVID-19 and TB syndemic: the way forward24
Post-tuberculosis sequelae: the need to look beyond treatment outcome24
Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda24
Clinical standards for the diagnosis, treatment and prevention of TB infection23
Severe COVID-19 cases with a history of active or latent tuberculosis23
Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis22
0.034962892532349